| Literature DB >> 32264936 |
Bo Hu1,2, Joy C Y Chen3, Yue Dong4, Ryan D Frank5, Melissa Passe6, Erica Portner6, Zhiyong Peng7, Kianoush Kashani8,9.
Abstract
BACKGROUND: Fluid resuscitation has become the cornerstone of early septic shock management, but the optimal fluid rate is still not well studied. The goal of this investigation is to examine the relationship between fluid resuscitation rate and septic shock resolution.Entities:
Keywords: Fluid resuscitation rate; Lactate clearance; Septic shock; Shock reversal; Vasopressor
Year: 2020 PMID: 32264936 PMCID: PMC7140334 DOI: 10.1186/s13054-020-2819-5
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Schematic representation of the study protocol. Time zero (T0) was the starting point of septic shock fluid resuscitation and defined as the first time that MAP < 65 mmHg or serum lactate > 2 mmol/l during the ICU stay. According to the different range of initial fluid resuscitation rate (equal to the slope in the graph), the cohort was divided into four groups: group 1 (≥ 0.5 ml/kg/min), group 2 (0.25–0.5 ml/kg/min), group 3 (0.17–0.25 ml/kg/min), and group 4 (< 0.17 ml/kg/min). The “” on the timeline marked ICU admission, shock reversal time (Tr), and ICU and hospital discharge; shock reversal time (Tr), ICU discharge, and hospital discharge must be after T0 but had no fixed time relationship with T0. The main variables and measurements of the study are shown in the bottom half of the figure. The period of shock reversal was defined as the duration between Tr and T0 (abbreviation: ICU = intensive care unit; T0 = time zero; T3 = 3 h after T0; Tr = shock reversal time; VIS = Vasoactive-Inotropic Score; LOS = length of stay)
Fig. 2The CONSORT flow diagram of patient enrollment (abbreviation: ICU = intensive care unit; SOFA = Sequential [Sepsis-related] Organ Failure Assessment; ICD = International Classification of Diseases; MAP = mean arterial pressure)
Clinical demographics and baseline characteristics by initial fluid resuscitation rate (ml/kg/min)
| Variables | Fluid replacement rate; ml/kg/min | ||||
|---|---|---|---|---|---|
| ≥ 0. 5, | 0.25–0.49, | 0.17–0.24, | < 0.17, | ||
| Age; year, median (IQR) | 66 (55, 78) | 68 (59, 80) | 70 (53, 79) | 67 (56, 77) | .5† |
| Male sex; | 126 (49%) | 65 (53%) | 40 (46%) | 296 (51%) | .7‡ |
| White race; | 242 (95%) | 114 (93%) | 79 (90%) | 526 (90%) | .2‡ |
| Hospital admission weight; kg, median (IQR) | 76 (63, 90) | 81 (64, 100) | 80 (67, 103) | 84 (69, 99) | < .001† |
| Charlson comorbidity index; median (IQR) | 5 (3, 8) | 6 (4, 8) | 6 (3, 8) | 6 (4, 8) | .9† |
| APACHE III score ( | 82 (64, 104) | 83 (69, 106) | 86.5 (73, 107) | 86 (70, 103) | .3† |
| SOFA score ( | 8 (6, 11) | 9 (7, 12) | 9.0 (6.5, 11.0) | 9 (6, 12) | .4† |
| Infection source | |||||
| Blood | 73 (29%) | 32 (26%) | 25 (28%) | 155 (26%) | .9 |
| Respiratory | 95 (37%) | 38 (31%) | 37 (43%) | 274 (47%) | .002 |
| Abdominal/GI | 44 (17%) | 13 (11%) | 10 (11%) | 78 (13%) | .2 |
| Urinary | 55 (21%) | 28 (23%) | 32 (37%) | 135 (23%) | .02 |
| Soft tissue and bone | 24 (9%) | 11 (9%) | 13 (15%) | 41 (7%) | .08 |
| Other | 23 (9%) | 13 (11%) | 12 (14%) | 54 (9%) | .5 |
| Heart rate ( | 101 (88, 116) | 100 (83, 113) | 105 (88, 117) | 98 (83, 111) | .007 |
| Mean arterial pressure ( | 64 (57, 73) | 60 (54, 68) | 65 (57, 75) | 66 (59, 76) | < .001 |
| VIS ( | 1.6 (0.5, 10.1) | 1.5 (0.6, 12.8) | 1.7 (0.7, 7.2) | 1.7 (0.6, 10.6) | .9 |
Numbers indicate N (%) unless otherwise noted
†Kruskal-Wallis
‡Chi-square
Comparison of outcomes by four different initial fluid resuscitation rate (ml/kg/min)
| Variables | Fluid replacement rate; ml/kg/min | ||||
|---|---|---|---|---|---|
| ≥ 0.5, | 0.25–0.49, | 0.17–0.24, | < 0.17, | ||
| Time to shock reversal; days | < .001‡ | ||||
| 232 | 103 | 73 | 506 | ||
| Median (Q1, Q3) | 1.6 (0.9, 3.3) | 1.4 (0.6, 3.2) | 2.0 (0.9, 4.6) | 2.4 (1.2, 5.1) | |
| Median survival | 1.72 (1.52, 2.01) | 1.87 (1.32, 2.62) | 2.58 (2.02, 4.40) | 2.80 (2.57, 3.26) | .004§ |
| Adjusted hazard ratioa | 1.00 (ref) | 0.96 (0.76, 1.21) | 0.84 (0.65, 1.10) | 0.78 (0.66, 0.91) ** | .01¶ |
| Lactate clearance; mg/dl | < .001‡ | ||||
| 207 | 97 | 62 | 400 | ||
| Median (Q1, Q3) | 0.5 (− 0.1, 1.3) | 0.4 (− 0.05, 1.2) | 0.6 (− 0.04, 1.2) | 0.2 (− 0.4, 0.8) | |
| Adjusted mean estimate c | 0.00 (ref) | 0.05 (− 0.27, 0.38) | 0.13 (− 0.25, 0.52) | − 0.45 (− 0.68, − 0.23)*** | < .001¶ |
| MAP change in the first 3 h; mmHg | < .001 ‡ | ||||
| 254 | 120 | 79 | 508 | ||
| Median (Q1, Q3) | 4.3 (− 3.0, 11.5) | 4.0 (− 4.5, 11.5) | − 0.5 (− 10.5, 7.0) | 0.5 (− 5.5, 7.0) | |
| Adjusted mean estimatec | 0.00 (ref) | − 1.14 (− 4.25, 1.96) | − 3.55 (− 7.17, 0.07) | − 2.93 (− 5.10, − 0.75)** | .04¶ |
| HR change in the first 3 h; bpm | .2‡ | ||||
| 255 | 120 | 82 | 545 | ||
| Median (Q1, Q3) | − 2.0 (− 7.5, 2.5) | − 2.3 (− 8.0, 4.3) | − 2.5 (− 9.5, 0.5) | − 1.5 (− 7.5, 3.5) | |
| Adjusted mean estimatec | 0.00 (ref) | 0.50 (− 2.06, 3.07) | − 1.41 (− 4.37, 1.54) | 1.63 (− 0.15, 3.41) | .08¶ |
| Fluid balance at | 59 (45, 79) | 44 (35, 60) | 33 (31, 41) | 7 (1, 15) | < .001‡ |
| Adjusted mean estimatec | 0.00 (ref) | 14.61 (10.63, 18.59)*** | 28.73 (24.23, 33.22)*** | 57.08 (54.34, 59.82)*** | < .001¶ |
| MICU fluid balance; ml/kg | 76 (48, 136) | 71 (40, 125) | 66 (24, 146) | 50 (16, 110) | < .001‡ |
| Adjusted mean estimatec | 0.00 (ref) | − 10 (− 34, 14) | − 6 (− 33, 21) | 13 (− 4, 29) | .1¶ |
| Fluid infusion between | 107 (50, 264) | 124 (49, 223) | 158 (62, 381) | 168 (86, 345) | < .001‡ |
| Adjusted mean estimatec | 0.00 (ref) | − 54 (− 102, − 5)* | 37 (− 18, 91) | 59 (27, 90)*** | < .001¶ |
| Duration between first vasopressor using and | < .001‡ | ||||
| 233 | 102 | 75 | 502 | ||
| Median (Q1, Q3) | 2.0 (0.5, 4.7) | 2.3 (1.3, 3.9) | 3.7 (1.4, 6.7) | 7.0 (2.2, 17.7) | |
| Adjusted mean estimatec | 0.00 (ref) | − 3.8 (− 12.5, 5.0) | − 2.0 (− 11.7, 7.8) | 10.3 (4.6, 15.9)*** | < .001¶ |
| SOFA change (day 2–day 1) | < .001‡ | ||||
| 240 | 114 | 80 | 561 | ||
| Median (Q1, Q3) | − 3 (− 5, − 1) | − 2 (− 5, − 1) | − 2 (− 3.5, − 0.5) | − 2 (− 4, 0) | |
| Adjusted mean estimatec | 0.00 (ref) | − 0.09 (− 0.71, 0.53) | 0.85 (0.15, 1.55)* | 0.94 (0.52, 1.36)*** | < .001¶ |
| Mechanical ventilation; | 134 (52%) | 68 (55%) | 55 (63%) | 383 (66%) | .002† |
| Adjusted odds ratiob | 1.00 (ref) | 1.04 (0.63, 1.75) | 1.56 (0.87, 2.83) | 1.91 (1.34, 2.73)*** | .001¶ |
| Mechanical ventilation duration; days | .002‡ | ||||
| 134 | 68 | 55 | 383 | ||
| Median (Q1, Q3) | 3 (1, 7) | 2 (1, 6) | 5 (2, 9) | 4 (2, 8) | |
| Adjusted mean estimatec | 0.00 (ref) | − 14.95 (− 66.76, 36.87) | 43.67 (− 11.93, 99.27) | 45.07 (9.60, 80.54)* | .01¶ |
| Discharge alive from MICU | 238 (93%) | 112 (91%) | 81 (92%) | 481 (82%) | < .001† |
| Median survival; days | 2.89 (2.64, 3.19) | 3.09 (2.42, 3.86) | 4.06 (3.12, 5.99) | 4.90 (4.51, 5.67) | < .001§ |
| Adjusted hazard ratioa | 1.00 (ref) | 0.95 (0.75, 1.19) | 0.74 (0.57, 0.95)* | 0.58 (0.49, 0.68)*** | < .001¶ |
| Discharge alive from hospital | 225 (88%) | 93 (76%) | 68 (77%) | 415 (71%) | < .001† |
| Median survival; days | 10.09 (8.51, 11.80) | 12.51 (9.77, 15.03) | 16.81 (13.66, 21.01) | 17.69 (15.45, 19.96) | < .001§ |
| Adjusted hazard ratioa | 1.00 (ref) | 0.84 (0.66, 1.08) | 0.58 (0.44, 0.76)*** | 0.53 (0.45, 0.63)*** | < .001¶ |
| MICU mortality; | 18 (7%) | 11 (9%) | 7 (8%) | 104 (18%) | < .001† |
| Adjusted odds ratiob | 1.00 (ref) | 1.34 (0.59, 3.03) | 1.12 (0.44, 2.87) | 3.40 (1.95, 5.93)*** | < .001¶ |
| Hospital mortality; | 31 (12%) | 30 (24%) | 20 (23%) | 170 (29%) | < .001† |
| Adjusted odds ratiob | 1.00 (ref) | 2.53 (1.41, 4.52)** | 2.23 (1.17, 4.27)* | 3.51 (2.27, 5.44)*** | < .001¶ |
| 28-day mortality; | 41 (16%) | 32 (26%) | 21 (24%) | 199 (34%) | < .001† |
| Adjusted odds ratiob | 1.00 (ref) | 1.97 (1.12, 3.45)* | 1.86 (0.99, 3.51) | 3.19 (2.13, 4.78)*** | < .001¶ |
Numbers indicate N (%) and median (Q1, Q3) unless otherwise noted
Unadjusted models contain just fluid resuscitation rate adjusted models are additionally adjusted for the effects of age, gender, white race, weight, CCI, APACHE III, and SOFA
Compared to ≥ 0. 5 ml/kg/min group, *P value < 0.05, **P value < 0.01, ***P value < 0.001
†Chi-square
‡Kruskal-Wallis
§Log-rank test
¶Type 3 Wald test
aAnalyzed using proportional hazards regression models
bAnalyzed using logistic regression models
cAnalyzed using linear regression models
Fig. 3The cumulative proportion of shock reversal and survival analysis with different initial fluid resuscitation rates (≥ 0.25 ml/kg/min vs. < 0.25 ml/kg/min). The shade indicates the confidence interval. a The cumulative proportion of shock reversal. Using Cox-model (additionally adjusted for the effects of age, gender, white race, weight, CCI, APACHE III, and SOFA), patients with ≥ 0.25 ml/kg/min rate had higher proportion of shock reversal (HR = 1.22; 95% CI 1.06–1.41; P = .007), with shorter median time (IQR) to shock reversal [1.5 (1.4, 1.7) vs. 2.3 (2.1, 2.6) days] for patients with < 0.25 ml/kg/min rate. b Survival analysis. Using Cox-model (additionally adjusted for the effects of age, gender, white race, weight, CCI, APACHE III, and SOFA), patients with ≥ 0.25 ml/kg/min rate had higher proportion of surviving (HR = 0.71; 95% CI 0.60–0.85; P < .001) for patients with < 0.25 ml/kg/min rate
Associations between fluid time and VIS by hour using univariate and multivariable GEE linear regression models
| Variables | Univariate analysis† | Multivariable analysis‡ | ||
|---|---|---|---|---|
| Mean estimate (95% CI) | Mean estimate (95% CI) | |||
| Fluid replacement rate; ml/kg/min | < .001 | < .001 | ||
| ≥ 0.5 | 0.00 (ref) | 0.00 (ref) | ||
| 0.25–0.49 | 0.18 (− 1.89, 2.24) | 0.11 (− 1.77, 2.00) | ||
| 0.17–0.24 | − 0.03 (− 2.34, 2.28) | − 0.15 (− 2.23, 1.92) | ||
| < 0.17 | − 2.62 (− 4.08, − 1.16) | − 2.41 (− 3.79, − 1.03) | ||
| VIS time (per 1 h) | 0.20 (0.15, 0.24) | < .001 | 0.18 (0.13, 0.22) | < .001 |
| Age (per year) | − 0.01 (− 0.05, 0.03) | .6 | − 0.03 (− 0.08, 0.02) | .2 |
| Male sex | − 0.07 (− 1.25, 1.11) | .9 | 0.33 (− 0.74, 1.41) | .5 |
| White race | − 0.73 (− 2.79, 1.34) | .5 | − 0.24 (− 2.18, 1.70) | .8 |
| Weight (per 10 kg) | − 0.5 (− 0.7, − 0.4) | < .001 | − 0.5 (− 0.7, − 0.3) | < .001 |
| Charlson comorbidity index | 0.02 (− 0.19, 0.23) | .9 | 0.04 (− 0.18, 0.27) | .7 |
| APACHE III score | 0.09 (0.07, 0.11) | < .001 | 0.05 (0.01, 0.08) | .007 |
| SOFA | 0.68 (0.52, 0.84) | < .001 | 0.41 (0.16, 0.66) | < .001 |
†Mean estimate and P value are adjusted only for the row covariate
‡Mean estimate and P value are adjusted for all covariates listed in the table
Fig. 4Association between fluid resuscitation rate (ml/kg/min) and VIS at variable time periods during the first 24 h of fluid resuscitation. Group < 0.17 ml/kg/min had significantly lower VIS at all time period. Compared to group < 0.17 ml/kg/min, *P value < 0.05, **P value < 0.01 (abbreviation: VIS = Vasoactive-Inotropic Score)